Nivolumab 600mg/5ml solution for injection vials
NHS hospitals in England used £70,748,183 of indicative cost of Nivolumab 600mg/5ml solution for injection vials in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is up 0.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nivolumab 600mg/5ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nivolumab 600mg/5ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Colchester Hospital University Nhs Ft | £10,829,529 |
| The Christie Nhs Foundation Trust | £6,524,047 |
| East And North Hertfordshire Nhs Trust | £5,007,966 |
| The Clatterbridge Cancer Centre Nhs Ft | £4,009,006 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,070,078 |
| Royal Free London Nhs Foundation Trust | £2,846,273 |
| Leeds Teaching Hpls Nhs Trust | £2,827,842 |
| Hull And East Yorkshire Hpls Nhs Trust | £2,696,192 |
| Western Sussex Hospitals Nhs Found Trust | £2,380,232 |
| Univ Hpls Bristol Nhs Foundation Trust | £2,111,666 |
The primary-care picture
Nivolumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Nivolumab medicine page.